Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-14

Clinical Trial Update: OMNI 3.1 Surgical System in Subjects With Primary Open-Angle Glaucoma [NA]

View source ↗

Summary

The OMNI 3.1 Surgical System is being studied in adults with Primary open-angle glaucoma and is currently recruiting. Sponsor: Sight Sciences, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sight Sciences, Inc. | Conditions: Primary Open Angle Glaucoma | NA | Status: RECRUITING